Physician profile
James L Head
NPI 1144541210
$7,772.92
in general payments reported to CMS, 2019-2025
21 companies · $52.36 in 2025
The $52.36 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,188 · 2020: $104 · 2021: $2,366 · 2022: $232 · 2023: $1,488 · 2024: $1,341 · 2025: $52.36.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,990 · Food and Beverage: $891.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,990.48 |
| Food and Beverage | $890.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $4,217.24 | 2019-2023 | |
| Stryker Corporation | $1,574.49 | 2019-2024 | Inbone |
| Midsouth Orthopedics INC. | $1,113.91 | 2021-2023 | |
| Radius Health, INC. | $152.79 | 2019-2024 | Tymlos |
| Amgen INC. | $136.22 | 2019-2025 | Evenity |
| Zimmer Biomet Holdings, INC. | $89.79 | 2022 | |
| Baudax Bio INC. | $82.81 | 2020-2021 | |
| Horizon Therapeutics Plc | $63.07 | 2019-2020 | |
| Pacira Therapeutics, INC. | $47.23 | 2019-2021 | |
| Polynovo North America LLC | $40.99 | 2024-2025 | Novosorb Btm |
| Bioventus LLC | $40.45 | 2019-2025 | Durolane |
| Heron Therapeutics, INC. | $32.77 | 2024 | Zynrelef |
| Smith+Nephew, INC. | $28.96 | 2019-2022 | |
| Crossroads Extremity Systems, LLC | $26.21 | 2019 | |
| Cerapedics INC. | $21.90 | 2024 | I-Factor Peptide Enhanced Bone Graft |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $21.57 | 2023 | |
| Kci USA, INC. | $20.05 | 2021 | |
| Osiris Therapeutics INC. | $19.98 | 2019 | |
| Ferring Pharmaceuticals INC. | $16.54 | 2019 | |
| Zimvie INC. | $14.69 | 2022 | |
| Becton, Dickinson and Company | $11.26 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Head listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.